Abstract
Since the early nineties the number of scientific papers dealing with the applications of artificial neural networks (ANNs) in medicinal chemistry and medicine fields has been dramatically increasing. In this review, the applications of artificial neural networks in QSAR, concerning the classification or prediction of a biological activity, conformation searching, receptor docking and molecular design, are reviewed over the last five years. The different models of neural network used, the selection of descriptors, the comparison of results obtained by employing ANNs and other computational methods in QSAR studies, are commented. An overview of the new computer program (CODES) to generate molecular descriptors by encoding organic molecules, which are useful inputs of neural networks, is provided.
Current Medicinal Chemistry - Central Nervous System Agents
Title: Applications of Neural Networks in the Medicinal Chemistry Field
Volume: 1 Issue: 3
Author(s): Carmen Ochoa, Antonio Chana and Manfred Stud
Affiliation:
Abstract: Since the early nineties the number of scientific papers dealing with the applications of artificial neural networks (ANNs) in medicinal chemistry and medicine fields has been dramatically increasing. In this review, the applications of artificial neural networks in QSAR, concerning the classification or prediction of a biological activity, conformation searching, receptor docking and molecular design, are reviewed over the last five years. The different models of neural network used, the selection of descriptors, the comparison of results obtained by employing ANNs and other computational methods in QSAR studies, are commented. An overview of the new computer program (CODES) to generate molecular descriptors by encoding organic molecules, which are useful inputs of neural networks, is provided.
Export Options
About this article
Cite this article as:
Ochoa Carmen, Chana Antonio and Stud Manfred, Applications of Neural Networks in the Medicinal Chemistry Field, Current Medicinal Chemistry - Central Nervous System Agents 2001; 1 (3) . https://dx.doi.org/10.2174/1568015013358419
DOI https://dx.doi.org/10.2174/1568015013358419 |
Print ISSN 1568-0150 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6158 |
Related Articles
-
Coumarin Derivatives as Adjuvants: From In Silico Physicochemical Characterization to In Vitro Evaluation against Gram Positive Bacteria
Combinatorial Chemistry & High Throughput Screening Newly Identified Tumor Antigens as Promising Cancer Vaccine Targets for Malignant Melanoma Treatment
Current Topics in Medicinal Chemistry T-Lymphocytes: A Target for Stimulatory and Inhibitory Effects of Zinc Ions
Endocrine, Metabolic & Immune Disorders - Drug Targets Anti-Oxidative Stress and Beyond: Multiple Functions of the Protein Glutathionylation
Protein & Peptide Letters Atranorin – An Interesting Lichen Secondary Metabolite
Mini-Reviews in Medicinal Chemistry Toll-Like Receptors, Cytokines and the Immunotherapeutics of Asthma
Current Pharmaceutical Design The Role of Intrinsically Disordered Regions in the Structure and Functioning of Small Heat Shock Proteins
Current Protein & Peptide Science Discovery and Development of Antibacterial Agents: Fortuitous and Designed
Mini-Reviews in Medicinal Chemistry Lock Stock and Barrel of Wound Healing
Current Pharmaceutical Design The Development of Biologically Important Spirooxindoles as New Antimicrobial Agents
Current Medicinal Chemistry Stopping of the Downtrend of Tuberculosis in Iran, a Systematic Review of Associated Risk Factors
Infectious Disorders - Drug Targets Diagnostic and Therapeutic Applications of Exosome Nanovesicles in Lung Cancer: State-of-The-Art
Anti-Cancer Agents in Medicinal Chemistry Small Heat Shock Proteins and Protein-Misfolding Diseases
Current Pharmaceutical Biotechnology Patent Selections
Recent Patents on DNA & Gene Sequences Bacterial Resistance: Antibiotics of Last Generation used in Clinical Practice and the Arise of Natural Products as New Therapeutic Alternatives
Current Pharmaceutical Design Prolyl Oligopeptidase: A Rising Star on the Stage of Neuroinflammation Research
CNS & Neurological Disorders - Drug Targets Morbidity and Mortality Associated with Pharmacotherapy. Evolution and Current Concept of Drug-Related Problems
Current Pharmaceutical Design Aspartic Peptidases of Human Pathogenic Trypanosomatids: Perspectives and Trends for Chemotherapy
Current Medicinal Chemistry New Biological Insights in the Immunomodulatory Effects of Mucosal Polybacterial Vaccines in Clinical Practice
Current Pharmaceutical Design Increase of R-/S-Methadone Enantiomer Concentration Ratio in Serum of Patients Treated with Either Nevirapine or Efavirenz
Drug Metabolism Letters